找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Biologic Therapy for Psoriasis; Cutting Edge Treatme Nicholas Brownstone,Tina Bhutani,Wilson Liao Book 2022 The Editor(s) (if applicable) a

[復(fù)制鏈接]
查看: 36326|回復(fù): 49
樓主
發(fā)表于 2025-3-21 18:44:52 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
期刊全稱Biologic Therapy for Psoriasis
期刊簡(jiǎn)稱Cutting Edge Treatme
影響因子2023Nicholas Brownstone,Tina Bhutani,Wilson Liao
視頻videohttp://file.papertrans.cn/188/187288/187288.mp4
發(fā)行地址Up-to-date and comprehensive review on biologic therapy for psoriasis.Includes cutting edge treatment principles based on the latest research.Examines the 11 FDA approved biologic agents currently on
學(xué)科分類Updates in Clinical Dermatology
圖書封面Titlebook: Biologic Therapy for Psoriasis; Cutting Edge Treatme Nicholas Brownstone,Tina Bhutani,Wilson Liao Book 2022 The Editor(s) (if applicable) a
影響因子.Biologic therapy is a treatment that strives to?modulate?a patient‘s immune system to fight a given disease. In psoriasis, a skin disorder that?is?partly caused by a dysregulated immune system resulting in?well-demarcated red areas of the skin with white scales, biologic therapy has the potential to vastly improve upon patient outcomes by minimizing the symptoms of?this disease while maximizing the safety profile of the therapy.??..?..This book offers an up-to-date and comprehensive review on biologic therapy for the treatment of psoriasis. With over 10?FDA approved biologic agents for psoriasis (with more in the pipeline), confusion exists among providers regarding which agent is best for a particular patient. Chapters cover all?FDA approved?psoriasis?biologic agents (including pipeline agents) for use in pediatric, adult, and geriatric patients. This book is unique in that it will not only cover cutting edge treatment principles based on the latest research, it will also be one of the most comprehensive reviews of psoriasis biologics in the COVID-19 era.??..?..Biologic Therapy for Psoriasis.?is a must-have resource for board certified dermatologists and rheumatologists, dermatol
Pindex Book 2022
The information of publication is updating

書目名稱Biologic Therapy for Psoriasis影響因子(影響力)




書目名稱Biologic Therapy for Psoriasis影響因子(影響力)學(xué)科排名




書目名稱Biologic Therapy for Psoriasis網(wǎng)絡(luò)公開度




書目名稱Biologic Therapy for Psoriasis網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Biologic Therapy for Psoriasis被引頻次




書目名稱Biologic Therapy for Psoriasis被引頻次學(xué)科排名




書目名稱Biologic Therapy for Psoriasis年度引用




書目名稱Biologic Therapy for Psoriasis年度引用學(xué)科排名




書目名稱Biologic Therapy for Psoriasis讀者反饋




書目名稱Biologic Therapy for Psoriasis讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:44:47 | 只看該作者
Asthma bronchiale im Kindesalterherapy can pose potential risks for patients with concomitant chronic infections including human immunodeficiency virus (HIV), tuberculosis (TB), hepatitis B (HBV), and hepatitis C (HCV). To date, many of these drugs have not been thoroughly studied for patients with chronic infections. Prescreening
板凳
發(fā)表于 2025-3-22 03:39:29 | 只看該作者
地板
發(fā)表于 2025-3-22 08:23:28 | 只看該作者
https://doi.org/10.1007/978-3-642-36999-5tor of this pathway, and overexpression of IL-17A results in epidermal hyperplasia and an inflammatory response, resulting in skin plaques and systemic inflammation. Targeted anti-IL-17 therapies have demonstrated efficacy and a favorable safety profile in key phase III clinical trials. Furthermore,
5#
發(fā)表于 2025-3-22 09:14:22 | 只看該作者
6#
發(fā)表于 2025-3-22 13:59:06 | 只看該作者
7#
發(fā)表于 2025-3-22 20:28:33 | 只看該作者
Kinderallergologie in Klinik und Praxisntial for, or presence of, associated comorbidities and the chronicity of psoriasis warrant systemic treatment in a subset of children with moderate-to-severe disease. Recent data have shown that biologics offer a safe and effective option for children. Currently, etanercept, ustekinumab, ixekizumab
8#
發(fā)表于 2025-3-22 23:16:22 | 只看該作者
9#
發(fā)表于 2025-3-23 03:07:13 | 只看該作者
Hagen Ott,Lars Lange,Matthias V. Koppdates for full-body therapy with either phototherapy or systemic agents. There is extensive evidence of efficacy and safety of the newer systemic therapies, biologics, of which there are currently 11 FDA-approved. They are compared directly to each other in head-to-head trials and indirectly through
10#
發(fā)表于 2025-3-23 08:07:38 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 20:06
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
墨脱县| 武乡县| 武夷山市| 大连市| 莱芜市| 新蔡县| 睢宁县| 礼泉县| 杭州市| 邵阳县| 德化县| 保靖县| 鹤山市| 苍梧县| 屏山县| 金阳县| 岑巩县| 九寨沟县| 莒南县| 兰考县| 岳西县| 湘阴县| 卢湾区| 黑山县| 从化市| 安义县| 连南| 平乐县| 扎鲁特旗| 建平县| 屏山县| 吉安县| 酉阳| 房山区| 绵阳市| 瑞昌市| 冷水江市| 铜川市| 乐亭县| 杂多县| 琼结县|